Concert Pharmaceuticals - CTP-656's Unit Acquisition

Concert Pharmaceuticals - CTP-656 raised a round of funding on March 24, 2017. Investors include Vertex Pharmaceuticals.

Concert was founded to utilize chemistry approaches to developing drugs. CTP-656 is a cystic fibrosis drug.…

Articles about Concert Pharmaceuticals - CTP-656's Unit Acquisition: